Our comprehensive services provide full management of the delivery of Investigational Medicinal Product (IMP) and any comparators you may require for your clinical trial.
Clinical trials are key to producing new innovative medicine: the benefits for patients are potentially life-changing; the rewards for pharmaceutical manufacturers, life-science and biotech companies as well as academic institutions, hospitals and any other contract research organisation, are potentially significant too. Yet they are expensive, complicated and challenging undertakings.
IPS Pharma participation in pre-clinical research and Phase 1 trial activity is limited. We do not currently manufacture new active pharmaceutical ingredient (API) molecules for use as an investigational medicinal product (IMP) when the pharmacodynamics, pharmacokinetics and unwanted pharmacological effects are being investigated.
The support services offered by IPS Pharma are most effective when used to support Phase 2 therapeutic exploratory trials, Phase 3 therapeutic confirmatory trials and Phase 4 post-marketing, label-claim extension clinical trials.